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Objectives: Oral lichen planus (OLP) is a chronic inflammatory oral mucosal disease. Cytokines play an important role in the pathogenesis and disease progression of 
OLP. Various reports have implicated cytokine gene polymorphisms in susceptibility to 
develop some immune mediated conditions including OLP. The purpose of this study was 
to investigate the association of tumor necrosis factor (TNF)-α, TNF-β and interleukin 
(IL)-10 gene polymorphisms with the OLP risk. Material and Methods: Forty two unrelated 
patients with OLP and 211 healthy volunteers were genotyped for TNF-α (-308 G/A), TNF-β 
(+252A/G), IL-10 (-1082G/A), IL-10 (-819C/T), and IL-10 (-592C/A) polymorphisms. 
Results: The frequencies of allele A and genotype GA of TNF-α (-308G/A) were significantly 
higher while allele G and GG genotypes were lower in OLP patients as compared to the 
controls (P<0.001). The frequency of GA genotype of TNF-β (+252A/G) was significantly 
higher in patients than in controls while the AA genotype was completely absent in OLP 
patients. These results indicated that allele A and genotype GA of TNF-α (-308G/A) as well 
as the GA genotype of TNF-β (+252A/G) polymorphisms are associated with OLP risk. The 
frequencies of alleles and genotypes of -1082G/A, -819C/T and -592C/A polymorphisms 
in IL-10 gene did not differ significantly between OLP patients and controls (P>0.05). 
However, haplotype ATA extracted from 1082G/A, -819C/T, -592C/A polymorphisms of IL-
10 were more prevalent in OLP patients when compared to controls indicating its possible 
association with OLP susceptibility. Conclusion: It is concluded that TNF-α (-308G/A), TNF-β 
(+252A/G) and IL-10 (-1082G/A, -819C/T and -592C/A) polymorphisms are associated with 
the susceptibility of OLP, thus giving additional support for the genetic basis of this disease.
Keywords: Oral lichen planus. Tumor necrosis factors. Interleukin-10. Genetic 
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INTRODUCTION
Oral lichen planus (OLP) is a chronic inflammatory 
oral condition whose etiology is not fully elucidated. 
It is the prototype of oral lichenoid lesions 
characterized by T-cell mediated immune responses 
and abnormal epithelial keratinization cycles6. 
OLP manifests as white striations, white papules, 
white plaques, erythema, erosions, or blisters 
predominantly affecting the buccal mucosa, tongue 
and gingival. The OLP lesions may co-exist with 
cutaneous and genital lesions, or may be the 
only disease manifestations. The prevalence of 
OLP ranges between less than 1 and 3% of the 
general population17. The prevalence of OLP in Arab 
countries including Saudi Arabia has been reported 
ranging from 0.35 to 1.7%2.
The OLP lesions are consistently more persistent 
than the dermal lesions and have been reported 
to carry a risk of malignant transformation to 
oral squamous cell carcinoma of 1-2% (reported 
range of malignant transformation 0–12.5%)10. 
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Clinically, OLP may be divided into three subtypes: 
reticular, erythematous (atrophic), and erosive23 
and more than one subtype of OLP may be present 
in an individual patient. The pathogenesis of OLP 
is very complex and involves possible antigen 
presentation by the oral keratinocytes that could 
be either of an exogenous or an endogenous 
origin9. This antigenic trigger is accompanied by a 
mixed inflammatory response comprising of mainly 
T-cells, macrophages, and mast cells, as well as the 
associated cytokines and cytotoxic molecules9,10. It 
is a disease associated with middle aged people and 
is more common among women4.
Cytokines play an important role in the 
pathogenesis and disease progression of OLP and 
a strong body of evidence suggests that OLP is 
a T-cell-mediated disease. The genetic factors 
that influence the immune function have been 
suggested to contribute to the OLP6,12. The gene 
polymorphisms of T-helper cell subtype Th1/Th2 
cytokines, tumor necrosis factor (TNF)-α, and 
interleukin-10 (IL-10) have been reported to affect 
the susceptibility to, and the progression of OLP3,14. 
Recently Chauhan, et al.8 (2013) suggested that 
proinflammatory cytokines are an important factor 
in understanding the disease burden of OLP and 
their comorbid factors. However, immunogenetic 
studies of OLP have given controversial results and 
the precise cause of OLP is still unclear.
TNF-α and TNF-β genes are located in tandem 
on chromosome 6 between the Class I and Class 
II cluster of the major histocompatibility complex 
(chromosome 6p21.1–6p21.3). TNF-α-308G/
Apolymorphism (rs1800629) has been reported 
to be associated with several autoimmune/
inflammatory diseases including OLP3,8. The genetic 
variation at position −308 of the TNF-α gene results 
in two allelic forms in which the presence of guanine 
(G) defines the common variant and the presence 
of adenine (A) defines the less common one. The 
A-allele of TNFα-308G/A polymorphism displays 
increased gene transcription as compared to the 
common allele G. It has been shown to produce 
levels of TNF-α transcription 6–7 fold greater31. 
TNF-β +252A/G polymorphism (rs909253) has 
been reported at position +252 within the first 
intron of the TNF-β gene, consisting of guanine 
(TNF-β +252G) on one allele and adenine (TNF-β 
+252Α) on the alternate allele18. The presence of 
G at this position defines the mutated allele known 
as TNF-β 1 (allele-1) which is a less frequent allele 
and is associated with higher TNF-α and TNF−β 
production18.
Interleukin-10 (IL-10) gene maps to the junction 
of 1q31-q32. It shifts the Th1/Th2 balance by down 
regulating the Th1 responses and by suppression 
of pro-inflammatory cytokines, such as TNF-α 
and interferon gamma (IFN γ) secretion26. Three 
promoter polymorphisms: -1082A/G (rs18000896), 
-819T/C (rs1800871) and -592A/C (rs1800872) are 
reportedly involved in the IL-10 transcription rate, 
thereby directly affecting its production level19. The 
-1082G, -819C and -592C alleles (GCC haplotype) 
have been associated with elevated levels of IL-10 
production15 while ACC and ATA haplotypes exhibit 
intermediate and low IL-10 gene transcription 
respectively27. In this study we examined the 
association of five single nucleotide polymorphisms 
(SNPs) of TNF-α, TNF-β, and IL-10 genes in the 
etiopathogenesis of OLP in Saudi patients.
MATERIAL AND METHODS
Study group
A total of 253 Saudi subjects visiting Prince 
Sultan Military Medical City (PSMMC), Riyadh, 
Saudi Arabia were recruited for this study. Forty 
two (16 male, 26 female) unrelated patients with 
oral lichen planus, ages ranging from 27 to 72 
years, and 211 (140 male, 71 female) unrelated, 
healthy patients matched voluntary blood donors 
with ages ranging from 20 to 65 years from the 
same population were studied for polymorphisms 
in TNF-α, TNF-β and IL-10 genes. Patients with any 
other inflammatory/autoimmune diseases were 
excluded from the study. This study was approved 
by the research and ethical committee of PSMMC 
and written informed consent was obtained from 
each subject before recruitment.
OLP was diagnosed according to the clinical 
manifestations and histopathological criteria of 
the World Health Organization. All patients were 
diagnosed through a review of the patient’s history, 
physical examination and histological findings 
by an oral pathologist. A 4 mm punch biopsy of 
lesional tissue that extends into the submucosa 
was performed. Symptoms were bilateral, more or 
less symmetrical lesions, and a lace-like network 
of slightly raised gray-white lines (reticular 
pattern). Erosive, atrophic, bullous, and plaque-
type lesions were only accepted as a subtype in 
the presence of reticular lesions elsewhere in the 
oral mucosa. Histopathological criterium were the 
presence of a well-defined band-like zone of cellular 
infiltration that was confined to the superficial 
part of the connective tissue, consisting mainly of 
lymphocytes, signs of “liquefaction degeneration” 
in the basal cell layer, and the absence of epithelial 
dysplasia28. No patient was suspected to have 
drug or restoration related lichenoid lesions, and 
no patient showed histologic signs of dysplasia. In 
cases where the clinical and histological findings 
were inconclusive, direct immunofluorescence 
(DIF) microscopy of perilesional mucosa was used 
to exclude autoimmune vesiculobullous disorders.
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PCR amplification
Genomic DNA was extracted from the peripheral 
blood of OLP patients and controls using the QIA 
ampR DNA mini kit (QIAGEN Hilden, North Rhine-
Westphalia, Germany). TNF-α, TNF-β and IL-10 
genes were amplified using amplification refractory 
mutation systems (ARMS)-PCR methodology21 to 
detect polymorphisms at positions -308 of TNF-α, 
+252 in intron1 of TNF-β and at loci -592, -819, and 
-1082 of IL-10 genes. PCR amplification was carried 
out using Ready to Go PCR Beads (GE Healthcare, 
Little Chalfont, Buckinghamshire, UK). Reactions 
consisted of 10 denaturation temperature cycles 
for 15 s at 94°C, annealing for 50 s at 65°C and 
extension for 40 s at 72°C. Then 25 denaturation 
cycles of 20 s at 94°C, annealing for 50 s at 59°C 
and then extension of 50 s at 72°C. Final extension 
was performed at 72°C for 7 min. A positive control 
was included in the PCR assay by amplification of 
the human growth hormone gene. The amplified 
products for the various samples were separated 
on the 1.5% agarose gel, stained with ethidium 
bromide and photographed.
Statistical analysis
The frequencies of alleles and genotypes were 
calculated. Hardy-Weinberg equilibrium was 
determined using Hardy-Weinberg Equilibrium 
Calculator for 2 Alleles (http//www.had2know.com/
academics/hardy-weinberg-equilibrium-calculator-
2alleles.html). The Bayesian method of the PHASE 
program (version 2.1) was applied to reconstruct 
the haplotype (http://stephenslab.uchicago.edu/
software.html). The differences in allele/genotype 
frequencies between patients and controls were 
analyzed by Fisher’s exact test using the CalcFisher 
software13. P values ≤0.05 were considered 
significant. The strength of the association of the 
disease with respect to a particular allele/genotype 
is expressed by odd ratio interpreted as relative risk 
(RR) following the Woolf’s method as out lined by 
Schallreuter, et al.22 (1993). It was calculated only 
for those alleles/genotypes which were increased 
or decreased in OLP patients when compared to 
the control group. The RR was calculated for all the 
subjects using the formula given below:
RR=(a×d)
   (b×c)
a = number of patients with expression of allele 
or genotype
b = number of patients without expression of 
allele or genotype
c = number of controls with expression of allele 
or genotype
d = number of controls without expression of 
allele or genotype.
Etiologic Fraction (EF) indicates the hypothetical 
genetic component of the disease. The values 0.0 
- 0.99 are of significance. EF was calculated for a 
positive association only where RR>1 using the 
following formula25.
EF=  (RR-1)f , where f =
        RR
Preventive Fraction (PF) indicates the hypothetical 
protective effect of one specific allele/ genotype 
for the disease. PF was calculated for negative 
association only where RR<1 using the following 
formula25. Values <1.0 indicate the protective effect 
of the allele/ genotype against the manifestation 
of disease.
PF=              , where f =
RESULTS
Among OLP patients the male to female ratio was 
16:26 (1:1.6). There was no significant difference in 
clinical manifestation or prognosis comparing men to 
women in our study. Thirty-five patients (83.333%) 
had lesions on the buccal mucosa, three (7.14 %) 
each on the tongue and gingival while one patient 
(2.39%) had lesions on the palate. The majority of 
patients (85%) had white lichen. In our patients, 
reticular type OLP was the commonest (80.95%) 
followed by erosive (23.81%) and then atrophic 
types (4.76%).
The genotype and allele frequencies of TNF-α 
(-308G/A) and TNF-β (+252A/G) promoter 
polymorphisms are presented in Table 1. In both 
the lichen planus patients and control groups the 
genotype distributions were in Hardy-Weinberg 
equilibrium. The frequency of the heterozygous 
genotype GA was significantly higher in OLP patients 
than in the control (P<0.001) whereas the frequency 
of homozygous genotypes GG was significantly lower 
in OLP than controls (P<0.001). The frequency of 
allele-A was significantly higher in OLP patients than 
control subjects (P<0.001). On the other hand, 
allele-G was significantly lower in OLP patients when 
compared to the control (P<0.001). The difference 
in frequency of the AA genotype between the two 
groups was not statistically significant.
The frequency of the GA genotype of TNF-β 
(+252A/G) promoter polymorphism was significantly 
higher in patients group than in the controls. 
Homozygous AA genotype was completely absent 
in OLP patients whereas it was present in 12% of 
the controls. The frequencies of alleles of TNF-β 
(+252A/G) polymorphism were not significantly 
different between OLP patients and healthy controls 
(Table 1). Albeit, the frequencies of allele-G were 
slightly higher in the OLP patients than they were 
in the control subjects.
(1-RR) f
RR(1-f)+f 
   a
(a+C)
       a
    (a+C)
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The results of SNPs for IL-10(-1082G/A), IL-
10(-592C/A), IL-10(-819C/T), and corresponding 
alleles and genotypes are summarized in Table 2. 
The genotype distributions of IL-10 polymorphisms 
in patient and controls were in Hardy-Weinberg 
equilibrium. The frequencies of -1082GG and 
1082GA genotypes were slightly higher while the 
frequency of -1082AA genotype was lower in OLP 
patients when compared to the control subjects, 
however, the differences were not statistically 
significant.
Similarly the frequencies of alleles and 
       
Genotype/ 
allele
OLP (N=42) Control (N=186)
N % N % P-value   RR EF*/PF
-1082G/A
GG 5 11.9 14 7.53 0.357 1.6 0.098*
GA 33 78.5 140 75.27 0.841 1.2 0.032*
AA 4 9.5 32 12.2 0.251 0.51 0.095
G-allele 43 51.2 168 45.16 0.334 1.3 0.047*
A-allele 41 48.8 204 54.84 0.334 0.78 0.048
-819C/T
CC 12 28.5 88 41.71 0.122 0.559 0.086
CT 25 59.5 102 48.34 0.239 1.5 0.065*
TT 5 11.9 21 9.95 0.78 1.2 0.032*
C-allele 49 62 278 65.88 0.521 0.846 0.026
T-allele 30 38 144 34.12 0.521 1.182 0.172*
-592C/A
CC 12 28.5 88 41.71 0.122 0.559 0.086
CA 25 59.5 102 48.34 0.239 1.5 0.065*
AA 5 11.9 21 9.95 0.78 1.2 0.032*
C-allele 49 62 278 65.88 0.521 0.846 0.026
A-allele 30 38 144 34.12 0.521 1.182 0.172*
N=number of subjects,*statistically  significant, RR=relative risk,  EF=etiologic fraction, PF=preventive fraction
Table 2- Genotype and allele frequencies of IL-10 variants in oral lichen planus patients and matched controls
           
Genotype/ 
allele
   OLP  (N=42)   Control (N=200)
    N  % N % P-value RR EF†/ PF
-308 G/A
GG 5 11.9 110 55 <0.001* 0.11 0.257
GA 36 85.72 76 38 <0.001* 9.789 0.288†
AA 1 2.38 14 7 0.479 0.324 0.121
G allele 46 54.76 296 74 <0.001* 0.425 0.153
A allele 38 45.24 104 26 <0.001* 2.351 0.153†
+252 A/G
GG 4 9.52 28 14 0.616 0.647 0.063
GA 38 90.48 148 74 0.025* 6.767 0.173†
AA 0 0 24 12 0.010* - -
G allele 46 54.76 204 51 0.55 1.163 0.026†
A allele 38 45.24 196 49 0.55 0.859 0.026
N=number of subjects,*statistically  significant, RR=relative risk,  EF=etiologic fraction, PF=preventive fraction
Table 1- Genotype and allele frequencies of TNF-α and TNF-β variants in oral lichen planus patients and matched controls
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genotypes of IL-10 (-819C/T) and IL-10 (-592C/A) 
polymorphisms did not differ significantly between 
OLP patients and controls (P>0.05). Albeit, the 
frequencies of genotypes -819 CT, -819 TT, 592 
CA and 592 AA were higher in OLP patients while 
-819 CC and -592 CC genotypes showed a reverse 
pattern with lower frequency in OLP patients when 
compared to the controls (Table 2). The frequencies 
of haplotypes extracted from 1082G/A, -819C/T, 
-592C/A polymorphisms of IL-10 are shown in Table 
3. The haplotype ATA was significantly increased in 
OLP patients when compared to controls (P=0.008).
The frequencies of alleles and genotypes of all 
five polymorphisms with gender are summarized in 
Table 4. No statistically significant difference was 
found in the frequencies of alleles or genotypes 
 Haplotype OLP (N=42) Controls (N=186)
N     (Frequency) N      (Frequency) P-value
GCC   7         (0.166) 42          (0.225) 0.533
ACC 13         (0.309) 82          (0.440) 0.165
ATA 20        (0.476) 48           (0.258) 0.008*
ACA   2         (0.047) 14           (0.075) 0.742
N=number of subjects,*statistically significant
Table 3- Haplotype analysis of IL-10 -1082G/A, -819T/C and -592C/A polymorphisms in OLP and control groups
Genotype/ allele Male (N=16) Female (N=26)
N % N % P-value
TNF-α (-308)
GG 2 12.5 3 11.54 1
GA 14 87.5 22 84.61 1
AA 0 0 1 3.85 0.99
G-allele 18 56.25 28 53.85 0.99
A-allele 14 43.75 24 46.15 0.99
TNF-β (+525)
GG 1 6.25 3 11.54 1
GA 15 93.75 23 88.46 1
AA 0 0 0 0 -
G-allele 17 53.13 29 55.77 0.82
A-allele 15 46.87 23 44.23 0.82
IL-10 (-1082)
GG 1 6.25 4 15.38 0.63
GA 15 93.75 18 69.23 0.12
AA 0 0 4 15.38 0.27
G-allele 17 53.13 26 50 0.82
A-allele 15 46.87 26 50 0.82
IL-10 (-819)
CC 6 37.5 6 23.08 0.48
CT 8 50 17 65.38 0.35
TT 2 12.5 3 11.54 1
C-allele 20 62.5 29 55.77 0.65
T-allele 12 37.5 23 44.23 0.65
IL-10 (-592)
CC 6 37.5 6 23.08 0.48
CA 8 50 17 65.38 0.35
AA 2 12.5 3 11.54 1
C-allele 20 62.5 29 55.77 0.65
A-allele 12 37.5 23 44.23 0.65
Table 4- Genotype and allele frequencies in male and female oral lichen planus patients
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of TNF-α, TNF-β and IL-10 gene polymorphisms 
between male and female OLP patients.
DISCUSSION
In this study 62% of the OLP patients were 
women. OLP has previously been reported to be 
more prevalent in females than males in American, 
British, Chinese, Iranian, Italian, Japanese and 
Spanish populations4,5,20. In our patients OLP was 
more frequent in the third to fourth decade of life 
and the median age of the patients group was 
42 years. Reticular OLP was the most common 
(80.95%) with the buccal mucosa as the most 
affected site (83.33%). These results are compatible 
with previous studies from various ethnic groups5,20. 
There was no significant difference in the clinical 
manifestation or prognosis when comparing men to 
women however, in our study, these observations 
should be taken with caution as the study’s sample 
size is small.
Our results on TNF-α promoter polymorphism in 
Saudi OLP patients suggested that genotype GA-
positive individuals at position -308 of TNF-α are at 
higher risk for OLP, whereas GG genotypes might be 
negatively associated with the disease. Data analysis 
further demonstrated that allele A (TNF-α 2 allele) 
increases the risk of OLP, whereas allele G (TNF-α 1 
allele) reduces OLP risk. Similarly higher frequencies 
of TNF-α 308 A allele and -308 GA genotype have 
been reported in Italian7, Indian8, and Chinese 
patients with an OLP3,12. Predominance of the AA 
genotype was also reported in Thai14 and Brazilian 
patients with OLP32. Further, genetic polymorphisms 
of cytokine-encoding genes are also known to 
predispose malignant diseases and have been 
associated with oral precancerous lesions (OPCLs). 
TNF-α (-308G/A), IL-6 and TGF-β polymorphisms 
have been associated with the development of 
OPCLs in Taiwanese patients11.
Allele A (TNF-α 2 allele) lies on the extended 
haplotype HLA-A1-B8-DR3-DQ2, which is associated 
with high TNF-α production. The allele A (TNF-α 2 
allele) has been demonstrated to be a much stronger 
transcriptional activator than the common allele 
G (TNF-α 1 allele)31. Moreover, TNF-α (-308G/A) 
promoter polymorphism has a direct effect on 
TNF-α gene regulation (increased TNF-α expression) 
and may be responsible for the association of 
allele A with the high TNF-α phenotype and more 
severe diseases31. Further populations bearing a 
higher proportion of the allele A (TNF-α 2 allele) 
are reportedly predisposed to several metabolic, 
degenerative, inflammatory, and autoimmune 
diseases1.
The results of this study also show that the 
GA genotype of TNF-β (+252 A/G) was positively 
associated with OLP risk, whereas genotype 
AA might be protective. This report is the first 
to show an association between TNF-β (+252 
A/G) polymorphism and OLP. This +252 A/G 
polymorphism on intron 1 of TNF-β is in linkage 
disequilibrium with a missense variant (Thr 26 Asn) 
in exon318. It is also closely linked to TNF-α, which 
is in linkage disequilibrium with HLA-A, B8, and 
DR330 and has been reported to define a high TNF-α 
expressing haplotype in addition to a modifying 
expression of TNF-β itself18. TNF-β (+252A/G) 
polymorphism has also been associated with 
numerous autoimmune diseases1. High serum and 
salivary levels of proinflammatory cytokine and TNF 
have been detected in OLP patients24. Thalidomide, 
a known TNF suppressant has been used to 
successfully treat OLP showing the implication of 
high TNF-α expressing genotypes of TNF-α and -β 
polymorphisms in the pathogenesis of OLP29.
Our results show no significant differences in 
the frequencies of alleles and genotypes of IL-
10 (1082G/A), IL-10 (-592C/A), IL-10 (-819C/T) 
polymorphisms between OLP patients and healthy 
Saudi controls. However, haplotype ATA from 
1082G/A, -819C/T, -592C/A of IL-10 had significant 
association with OLP in Saudi patients. Two other 
studies dealing with the IL-10 gene polymorphisms 
in OLP populations could also not find any difference 
in the frequencies of IL-10 alleles and genotypes 
between the patients with OLP and healthy 
controls3,32. However,the -1082A/-819T/-592A 
(ATA) haplotype of the IL-10 polymorphisms, which 
correlated with a lower serum level of IL-10, has a 
significant association with OLP in a Chinese cohort 
with Han ethnicity3. Thus, this study together with 
the study from China supports that the low producer 
ATA haplotype of IL-10 polymorphisms is linked to 
the risk of OLP.
Our results also indicated that the frequencies of 
alleles and genotypes of all the five polymorphisms 
studied are independent of gender (Table 4). 
However, these results should be taken with caution 
as the number of males and females is too low for 
any significant conclusion.
Besides TNF-α and IL-10, a number of 
inflammation and immune regulation-related 
cytokines, including interferon-gamma (IFN-γ), 
IL-4, and IL-8, have been suggested to have an 
important role in the pathogenesis of OLP. Abnormal 
expression patterns of various inflammation-related 
cytokines, including IL-10, and TNF-α, in lesions, 
saliva, serum and peripheral blood mononuclear 
cells from patients with OLP has also been reported, 
which may reflect the immune dysregulation status 
of cytokines and emergence as central players in the 
immunopathogenesis of OLP16. Recently Carrozzo7 
(2014) suggested that the pro inflammatory milieu 
associated with degranulated mast cells might 
play a role in helping T cells breach the epidermal 
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basement membrane in OLP lesions.
CONCLUSION
The polymorphisms in TNF-α (-308), TNF-β 
(+252) and IL-10 (-1082, -819 and -592) gene 
are associated significantly with the risk of OLP 
susceptibility. However, further studies are required 
that use a larger sample size to confirm this 
association.
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